Volvo signs long-term battery supply deal with LG Chem & CATL
By Akshay Kedari  Date: 2019-05-17

Volvo signs long-term battery supply deal with LG Chem & CATL

The U.S. has recently sought to limit dominance of China in EV supply chain.

Swedish luxury vehicle company Volvo Cars Group has reportedly announced that it has signed a long-term agreement with Asian companies Contemporary Amperex Technology Co Ltd (CATL) and LG Chem for battery supply. The move comes as a push to the Volvo’s electric vehicle (EV) target of 50 percent of sales by the year 2025.  

Reportedly, the deal has followed several pacts between global carmakers and Asian battery companies, who have planned to increase their spending on EV technology up to $300 billion over the decade.

Long-term arrangements for battery supply seemingly help to clear supply bottleneck at a time of soaring demand and hold out the promise of cheaper batteries over time. Thus, they are much valued by investors and carmakers.

Volvo Cars has reportedly been investing around $1 billion a year, which totals about 5 percent of its annual revenue, on driverless and electric cars.

Volvo cars will be introducing EV models under the Polestar and Volvo marquee to take on the global peers, such as Tesla, General Motors and Volkswagen.

Reportedly, Volvo has plans to get 50 percent of its sales from fully electric cars by the year 2025. The company foresees its margins on electric cars to match the vehicles equipped with combustion engines by that time.

Hakan Samuelsson, CEO and President, Volvo Cars, reportedly noted that the future of Volvo Cars is electric, and the company is firmly committed to move beyond the internal combustion engine.

Apparently, the batteries by European automakers are typically sourced from companies in Japan, China and South Korea, which dominate the EV batteries supply chain.

The U.S. has recently sought to limit dominance of China in EV supply chain.

The deal of Volvo has raised the shares of CATL and LG Chem over 3 percent, cited reliable sources.

The financial terms of the deal have not been disclosed yet. But the companies have reportedly stated that the battery deals were valued at several billion dollars.

 

Source credit: https://in.reuters.com/article/us-lg-chem-volvo/volvo-signs-ev-battery-supply-deals-with-lg-chem-catl-idINKCN1SL0C0

https://www.media.volvocars.com/global/en-gb/media/pressreleases/252485/volvo-car-group-signs-multi-billion-dollar-battery-supply-deals-with-catl-and-lg-chem

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...